Evidence map›Paper›PMID 17052264›Full record

ReviewCancer science2006

Cancer research with non-coding RNA.

Yasuhiro Tomaru, Yoshihide Hayashizaki

Abstract readReview
In one paragraph

Review in Cancer science, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Tissue Expression Difference between mRNAs and lncRNAs.International journal of molecular sciences · 2018
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells.Proceedings of the National Academy of Sciences of the United States of America · 2007
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Yasuhiro TomaruRIKEN Yokohama Institute, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama City, Kanagawa 230-0045, Japan.
Yoshihide Hayashizaki

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer research is not limited to medical research; it expands over several disciplines, incorporating molecular bioscience at both the macro and micro levels. All stages and aspects of cells, from development and differentiation, apoptosis, cell adhesion and many more, are research fields with a connection to cancer. Cancer research in itself is the research of cancer cures. Recently, not only cancer but also bioscience research has surfed on the new wave of RNA knowledge. Most of those RNAs are non-protein-coding RNAs and are connected to cell development and differentiation, and thereby with cancer differentiation and treatment. Here we would like to introduce the latest in cancer research that has emerged from the field of molecular biology research.

Indexed as

Cell DifferentiationHumansMicroRNAsNeoplasmsRNA, NeoplasmRNA Processing, Post-TranscriptionalRNA, Small InterferingRNA, UntranslatedTranscription, GeneticMicroRNAsRNA, NeoplasmRNA, Small InterferingRNA, Untranslated

Identifiers

PMID17052264
PMCPMC11158021

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.